Case File
efta-02518645DOJ Data Set 11OtherEFTA02518645
Date
Unknown
Source
DOJ Data Set 11
Reference
efta-02518645
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From:
Jeffrey Epstein <[email protected]>
Sent:
Sunday, January 12, 2014 8:56 PM
To:
Tazia Smith
Subject:
Re: PVDSA chart + USDJPY Trade (C]
do you think money good in 15
On Sun, Jan 12, 2014 at 4:38 PM,=Tazia Smith
<mailto
> wrote:
Classification: Co=fidential
Jeffrey:
Please find the chart of PDVSA 5% =0/28/15 price history below, as well as a description of the USDJPY 10yr
trade that we briefly discussed on Friday.
Speak with you soon,
Tazia
Used with permission of Bloombe=g Finance LP, 1/10/14
Forwarded =y Tazia Smith/db/dbcom on 01/12/2014 03:29 PM
From: Nav Gupta
To:
Tazia Smith
01/10/2014 08:21 AM
Subject:
SY [I]
Classification: For internal us= only
Long $Y Call Options. We like long expiry options to benefit from the prese=t dislocation between interest rates
and volatility
Deutsche Bank FX Strategists are c=lling for USDJPY of 115 by year-end 2014, and 120 by year-end 2015. See DB
FX Blueprint published 1/9/14, and note that #2 of the top 10 themes of 2014 (p. 5-6) revolves around extended
weakness in the Japanese Yen vs. USD.
Consider a 10year expiry $Y call op=ion struck at 85 (spot fx 105, forward fx 77.70). Price 4.7% of USD notional
EFTA_R1_01654373
EFTA02518645
This option has four notable chara=teristics
•
If $Y stays at these levels the option decays positively by approx 15.20% per year
•
If $Y trades 90.00 at any tim= (arguably a scenario in which the option is no longer wanted) the option
"knocks=out" and becomes worthless. While $11 might decline to 90, our quantitative analy=is indicates the probability
of such a decline is significantly (double?) overpriced by the options market
•
The premium of the option is =uite sensitive to moves in $Y spot - which is atypical for a 10year option.
This also results from the knockout feature. This means if $Y moves quickly by 5% the option increases / decreases in
value by almost half, so If SY rises to 110 or 115 the option can easily be unwound to monetize the profit
•
The option costs roughly 1/3r= compared to the vanilla 85 strike call
•
Maximum loss is premium paid<=font>
Tazia Smith
Director I Key Client Partners - US
Deutsche Bank Securities Inc
Deutsche Asset & Wealth Management
345 Park Avenue, 26th Floor
New York, NY 10154
Tel.
<tek%
Fax
<telAMMOOMONEMinin>
Mobile
<tel:°
Email
<mailto:
This communication may contain confidential and/=r privileged information.
If you are not the intended recipient (or have received this communication<=r> in error) please notify the sender
immediately and destroy this
communication. Any unauthorized copying, disclosure or distribution of the<=r> material in this communication
is strictly forbidden.
Deutsche Bank does not render legal or tax advice, and the information
contained in this communication should not be regarded as such.
<=>
2
EFTA_R1_01654374
EFTA02518646
The information contained in =his communication is confidential, may be attorney-client privileged, may constitute
inside i=formation, and is intended only for the use of the addressee. It is the=property of Jeffrey Epstein Unauthorized
use, disclosure or copying=of this communication or any part thereof is strictly prohibited and may be unla=ful. If you
have received this communication in error, please notify us=immediately by return e-mail or by e-mail to
[email protected] <mailto:[email protected]> , and destroy this communication and all copies thereof,
including all attachm=nts. copyright -all rights reserved
3
EFTA_R1_01654375
EFTA02518647
Technical Artifacts (5)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.